Efficacy and safety of extracorporeal shock wave therapy combined with sodium hyaluronate in treatment of knee osteoarthritis: a systematic review and Meta-analysis.
Systematic Review
To assess the efficacy and safety of extracorporeal shockwave therapy (ESWT) combined with sodium hyaluronate (HA) for the treatment of knee osteoarthritis (KOA)./r/nPubMed, Embase, the Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang database, China Science and Technology Journal Database, and SinoMed were searched from inception to July 2020. The quality of the randomized controlled trials was evaluated independently by two reviewers according to the criteria in the Cochrane Collaboration for Systematic Reviews. The identified articles were then screened individually using EndnoteX9 for eligibility in this Meta-analysis. The heterogeneity among the articles was evaluated using I2./r/nA total of 17 studies, comprising 2000 individuals, were included in this Meta-analysis. The results showed that a significant improvement was observed in knee pain and function based on the clinical efficacy of ESWT combined with HA. Statistical analysis of clinical efficacy showed that [relative risk () = 1.21, 95% confidence interval () (1.12, 1.30), 0.01]. Statistical analysis of visual analog scale showed that [standardized mean difference () = －2.84, 95% (－4.01, －1.66), 0.01]. Western Ontario and McMaster University osteoarthritis index statistical analysis showed that [ = －1.57, 95% (－2.52, －0.61), 0.01]. Lysholm score statistical analysis showed that [ = 1.71, 95% (0.98, 2.44), 0.01]. In addition, only minor side effects, such as redness and swelling of the skin, were observed./r/nMedium to low quality evidence showed that ESWT combined with HA offers an inexpensive, well-tolerated, safe, and effective method to improve pain and functionality in patients with KOA. However, tightly controlled, randomized, large multicenter trials are warranted to validate the current findings.
